to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.
Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.
Antineoplastic Agents, Alkylating
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy.
Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.
Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors.
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.
Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.